Académique Documents
Professionnel Documents
Culture Documents
AN IMMUNOARRAY FOR THE SIMULTANEOUS DETECTION OF TWO MYCOTOXINS, OCHRATOXIN A AND FUMONISIN B1
jfs_314 408..416
XICHUN WANG1,2, HAIBIN ZHANG1,3, HAIMING LIU1, CHENGHUA HE1, AIHUA ZHANG1, JINRONG MA1, YANNA MA1, WENDA WU1 and HAO ZHENG1
1 2
College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, Jiangsu, China College of Animal Science and Technology, Anhui Agricultural University, Hefei, Anhui, China
Corresponding author. TEL: +86-25-84396478; FAX: +86-25-84396434; EMAIL: haibinzh@njau.edu.cn Accepted for Publication February 17, 2011 doi:10.1111/j.1745-4565.2011.00314.x
ABSTRACT
The two mycotoxins Ochratoxin A (OTA) and Fumonisin B1 (FB1) generate substantial global concern due to their toxicity in both humans and animals. Herein we describe the development of an immunoarray to detect these toxins. The immunoarray was prepared by immobilization of two antigen (Ag) conjugates on aldehydized slides. Standard curves were plotted, and the experimental conditions were optimized. The sensitivities were 5.43 ng/mL and 109.06 ng/mL, with detection ranges of 0.11 0 and 5200 ng/mL for OTA and FB1, respectively, with good logistic and linear correlation (R2 > 0.99). Next, unknown samples were detected by immunoarray and enzyme-linked immunosorbent assay (ELISA). The errors were relatively small for both methods, while the detection range of the immunoarrays was broader and more sensitive than traditional ELISA. The high-throughput immunoarray is a novel method for concurrent analysis of multiple mycotoxins that is technically simple, highly sensitive and relatively inexpensive.
PRACTICAL APPLICATIONS
The immunoarray technique used in this study provides an analytical tool with the specicity and sensitivity for rapid detection of two mycotoxins, Ochratoxin A and Fumonisin B1.
INTRODUCTION
Mycotoxins are secondary metabolites produced by various fungi which contaminate a large variety of foods, with toxic effects to animals and human. Ochratoxin A (OTA) is mainly produced by Aspergillus and Penicillium species (Simarro doorten et al. 2004; Ringot et al. 2006), and is a worldwide common contaminant of cereal grains (Duarte et al., 2010), coffee (Mantle 2000; Joosten et al. 2001), grapes (Sage et al. 2002), red wine (Visconti et al. 1999; Castellari et al. 2000) and beer (Medina et al. 2005). It is also found in human blood, urine and milk, as well as in animal blood and tissues (Creppy et al. 1995). OTA is nephrotoxic, hepatotoxic, teratogenic and immunotoxic to several species of animals, and cause kidney and liver tumors in mice and rats (Ringot et al. 2006). Moreover, OTA is suspected to be involved in the etiology of Balkan endemic nephropathy, a human chronic inter408
stitial nephropathy which is most often associated with urinary tract tumors (Pfohl-Leszkowicz et al. 2002). Fumonisin B1 (FB1) is primarily produced by Fusarium moniliforme. The natural occurrence of FB1 has been reported in many areas worldwide in maize and maize-based products (Paepens et al. 2004). FB1 induces equine leukoencephalomalacia (Wilson et al. 1992), pulmonary edema in pigs (Motelin et al. 1994), hepatotoxicity and hepatocarcinogenesis in rats (Gelderblom et al. 2001), hepatopathy and nephrosis in sheep (Colvin and Harrison 1992), and immunosuppression in poultry. Epidemiological evidence also indicates a possible correlation between human esophageal cancer and fumonisins (Yoshizawa et al. 1994; Pitt 2000; Marasas 2001). OTA and FB1 were classied by the International Agency for Research on Cancer as possible human carcinogens (group 2B) (International Agency for Research on Cancer [IARC] 1993, 2002).
Journal of Food Safety 31 (2011) 408416 2011 Wiley Periodicals, Inc.
X. WANG ET AL.
Rapid and accurate detection of trace chemical targets and studies on interactions between bio-macromolecules and small molecules (Delaunay-Bertoncini et al. 2003; Liu et al. 2007) remain formidable challenges in analytical elds. Microarrays provide a highly sensitive and precise technique for obtaining information from biological samples (MacBeath and Schreiber 2000; Du et al. 2005). Unlike DNA arrays, which are based on nucleic acid hybridization on a surface-immobilized template, protein chips or arrays have different proteins imprinted on solid support (such as glass slides, silicon and gel, etc.) as probes to analyze interactions between different proteins (Chiem and Harrison 1998; De wildt et al. 2000). With high-throughput, miniaturization, minimal reagent, parallelism and automation, protein arrays are becoming increasingly important tools for protein interaction studies and diagnostics. Immunoarrays are based on the molecule-specic immunological recognition of antigens (Ags) or antibodies (Abs) by Abs or Ags immobilized on the surface of a solid slides. When complementary Ags or Abs reacts with the probes on the array, an array image of the uorescent intensity (FI) can be captured by a laser scanner and analyzed by computer software. Simultaneously, high-output, automatic, highsensitivity multi-analysis may be achieved. There is only one binding site for each small molecule, which means the competitive method should be used. However, detection of these materials in food and foodstuffs with protein arrays or immunoarrays is seldom reported. In recent years, the risks associated with mycotoxin contamination of foods and animal feed has promoted the development of analytical methods to detect these toxins reliably. Thin-layer chromatography (Rottinghaus et al. 1992; Santos and Vargas 2002), high-performance liquid chromatography (Paepens et al. 2005; Ghali et al. 2009), enzyme-linked immunosorbent assay (ELISA) (Wang et al. 2006; Erkekoglu et al. 2010) and electrochemical immunosensor (Abdul Kadir and Tothill 2010) have been used extensively for the detection of these materials. However, chromatography methods are expensive and time consuming, and require appropriate instrumentation and trained personnel. ELISA-based kits have become the most popular and useful screening tool, but are generally expensive and suffer from cross-reactivity, producing false positive results. Immunosensor techniques are a major development in screening methods for mycotoxin determination. The advantages of immunosensors over conventional ELISA methods are: increased sensitivity and decreased lower detection limit,, cost effectiveness and ease of use, decreased requirement for expensive reagents and the portability of the devices, which provide digital signal readout (Tothill 2001). In the present work, we explored the feasibility of detecting two mycotoxins with an immunoarray.
Journal of Food Safety 31 (2011) 408416 2011 Wiley Periodicals, Inc.
X. WANG ET AL.
IgG secondary antibody were added, in turn, for the Ag-Ab competitive reactions. Meanwhile, in order to test the specicity of the two mAbs, blanks used as controls, i.e., OVA and deoxynivalenol (DON)-OVA, were spotted as well.
X. WANG ET AL.
FIG. 2. SCANS OF CONTROL (OVA), AND DON-OVA TO VALIDATE THE TWO ANTIGEN CONJUGATES (OTA-OVA AND FB1-OVA) The concentrations of OTA-OVA and FB1-OVA were 30 mg/mL and 40 mg/mL, respectively. The added OTA and FB1 mAbs were diluted 1,600 and 1,200, and the secondary antibody was added at a concentration of 2 mg/mL. FB1, Fumonisin B1; OTA, Ochratoxin A; OVA, ovalbumin.
TABLE 1. THE OTA-OVA FLUORESCENCE INTENSITY OTA mAb OTA-OVA (mg/mL) FIG. 1. MASS SPECTROGRAMS OF THE TWO MYCOTOXIN CONJUGATES (a) For OTA-OVA, the MW was 50,350.141, as determined by mass spectroscopy, and the coupling ratio was 13:1; (b) For FB1-OVA, the MW was 51,928.612, determined by mass spectroscopy, and the coupling ratio was 9.6:1. FB1, Fumonisin B1; OTA, Ochratoxin A; OVA, ovalbumin. 20 30 40 60 1/400 32,222 39,300 40,923 39,888 1/800 28,107 36,447 37,948 36,953 1/1600 25,573 33,918 35,764 32,125 1/3200 20,749 29,706 32,390 29,339
The FIs for 30 mg/mL and 60 mg/mL OTA-OVA were very similar; 30 mg/mL was selected as the optimum OTA-OVA concentration. OTA mAb diluted 1,600 was selected (uorescence intensity 30,00035,000), and the secondary antibody was added at 2 mg/mL concentration. FI, uorescence intensities; OTA, Ochratoxin A; OVA, ovalbumin.
These data show that the FIs increase as the Cy3conjugated goat anti-mouse IgG secondary antibody concentration increases. However, lower secondary antibody concentration may narrow the detection range; higher secondary antibody concentration would increase the expense. Therefore, 2 mg/mL Cy3-conjugated goat anti-mouse IgG secondary antibody was selected (FI 30,00035,000; Fig. 3). The highest signal to noise (S/N) ratio was obtained when the xed condition of Ag conjugates were xed at 4C overnight and blocked in 1% BSA blocking for 1h at 37C (Fig. 4).
Journal of Food Safety 31 (2011) 408416 2011 Wiley Periodicals, Inc.
Lower S/N ratios or high background was related to inappropriate xing conditions and blocking time. Overnight incubation with 4C may allow sufcient condensation reaction, and blocking for 1 h can block nonreactive sites completely. Furthermore, when OTA-OVA reacted with OTA-mAb for 1 h, we obtained the highest FI (34,219), but there was no statistically signicant increase at 2 h (Fig. 4). Subsequent Ag-Ab reactions were incubated for 1 h. Prolonging the Ag-Ab reaction beyond 2 h might decrease Ab activity, but it
411
X. WANG ET AL.
TABLE 2. THE FB1-OVA FLUORESCENCE INTENSITY FB1 mAb FB1-OVA (mg/mL) 20 30 40 60 1/400 25,176 32,708 47,659 46,551 1/800 21,102 30,557 41,050 38,784 1/1200 15,945 26,232 34,730 36,338 1/1600 11,660 13,545 19,678 23,033
The FIs for 40 mg/mL and 60 mg/mL FB1-OVA were very similar; 40 mg/mL was selected as the optimum concentration. FB1 mAb diluted 1,200 was selected (uorescence intensity 30,00035,000), and the secondary antibody was added at 2 mg/mL concentration. FB1, Fumonisin B1; FI, uorescence intensities; OTA, Ochratoxin A; OVA, ovalbumin.
FIG. 3. RELATIONSHIP BETWEEN CY3-CONJUGATED GOAT ANTI-MOUSE IgG SECONDARY ANTIBODY CONCENTRATION AND FLUORESCENCE INTENSITY Bars 14 represent different concentration of goat anti-mouse IgG-CY3 secondary antibody relative to the uorescence intensity.
did not decrease within 2 h. The xing conditions and blocking time of FB1-OVA, and the Ag-Ab incubation time, were similar to OTA.
FIG. 4. OPTIMIZATION OF DIFFERENT REACTION CONDITIONS Relationship between the incubation conditions of the OTA-OVA conjugate to the S/N ratio to optimize the protocol. (A) xed at 37C for 1 h (a), at 4C for 1 h (b), or at 4C overnight (c); (B) blocked for 0.5 h (a), 1 h (b), or 2 h (c); and (C) mAb immobilization for 0.5 h (a), 1 h (b) or 2 h (c). Ag, antigen; Ab, antibodies; OTA, Ochratoxin A; OVA, ovalbumin.
and they deviated from the standard curve. So the limit of quantitation (LOQ) of OTA and FB1 in the method was in accord with their detection ranges. Because of the variance of inter-arrays and inevitable errors, repetition and stability are still major problems for immunoarrays, requiring further optimization. For this reason, standard curves must be plotted each time when the immunoarray is used. In order to test the specicity of the immunoarray, it was exposed to a mixture of Abs. Figure 6a,b show that there was no cross-reaction between OTA and FB1. In Fig. 6c, after the OTA and FB1 mAbs reacted with their complementary Ag conjugates spotted on the slide, the addition of Cy3-conjugated goat anti-mouse IgG secondary antibody
Journal of Food Safety 31 (2011) 408416 2011 Wiley Periodicals, Inc.
X. WANG ET AL.
CONCLUSIONS
Our present work demonstrated that immunoarrays can simultaneously detect two mycotoxins, OTA and FB1, with a sensitivity (IC50) of 5.43 ng/mL (OTA) and 109.06 ng/mL (FB1), and detection ranges between 0.110 ng/mL (OTA) and 5200 ng/mL (FB1) with good logistic and linear correlation (R2 > 0.99). However, the repeatability and stability of immunoarrays must be optimized, and more mycotoxins should be integrated in the arrays in further studies. With the development of processing and preparation technologies and access to high-quality Abs, and as a sensitive, rapid and highthroughput method, immunoarray will have an important role in the detection of various mycotoxins in agricultural products and foodstuffs.
FIG. 5. IMMUNOARRAY STANDARD CURVES FOR THE TWO MYCOTOXINS (a) Standard curve for OTA, at nal concentrations of 0.1, 0.5, 1.25, 2.5, 5 and 10 ng/mL; (b) Standard curve for FB1, at nal concentrations of 5, 10, 25, 50, 100 and 200 ng/mL. FB1, Fumonisin B1; OTA, Ochratoxin A.
produced strong FIs. In Fig. 6d, after the addition of the mixture of OTA (5 ng/mL) and FB1 (100 ng/mL) mAbs, the FIs were sharply decreased. The most crucial factors for the OTA and FB1 mAbs used in immunoassays are good bioactivity and specicity. Phage display technology (Hust and Dubel 2004; Lensen et al. 2006) and ribosome display technology (Dufner et al. 2006) are alternative tools for generating high-quality Abs. Abs with higher titer and specicity, especially mAbs, can signicantly increase the accuracy and sensitivity of the immunoarray.
ACKNOWLEDGMENTS
This study was nancially supported by the National High Technology Research and Development Program of China (2007AA10Z429).
TABLE 3. SAMPLE DETECTION FOR TWO MYCOTOXINS BY IMMUNOARRAY AND ELISA Available MFI ( X s, n = 3) 32,278.16 216.59 27,210.35 168.46 18,733.28 145.34 30,828.00 229.75 15,507.19 164.83 10,660.01 117.13 Found by immunoarray (ng/mL) 0.46 2.11 4.87 9.86 113.47 139.25 Found by ELISA ( X s, n = 3, ng/mL) 120.36 8.28 158.12 9.19 Real (ng/mL) 0.5 2 5 10 100 150 RSD by immunoarray (%) 5.62 7.86 8.09 7.53 8.47 9.56 RSD by ELISA (%) 9.84 8.29
413
X. WANG ET AL.
FIG. 6. SIMULTANEOUS DETECTION OF BOTH MYCOTOXINS Images of the chips after addition of Abs as follows: (a) OTA mAb; (b) FB1 mAb; (c) OTA and FB1 mAb; (d) mixture of OTA (5 ng/mL) and FB1 (100 ng/mL), and then the of OTA and FB1 mAbs were added. FB1, Fumonisin B1; OTA, Ochratoxin A; OVA, ovalbumin.
REFERENCES
ABDUL KADIR, M.K. and TOTHILL, I.E. 2010. Development of an electrochemical immunosensor for fumonisins detection in foods. Toxins 22, 335344. CASTELLARI, M., FABBRI, S., FABIANI, A., AMATI, A. and GALASSI, S. 2000. Comparison of different immunoafnity clean-up procedures for high-performance liquid chromatographic analysis of ochratoxin A in wines. J. Chromatogr. A 888, 129136. CHIEM, N.H. and HARRISON, D.J. 1998. Microchip systems for immunoassay: An integrated immunoreactor with electrophoretic separation for serum theophylline determination. Clin. Chem. 44, 591598. COLVIN, B.M. and HARRISON, L.R. 1992. Fumonisin-induced pulmonary edema and hydrothorax in swine. Mycopathologia 117, 7982. CREPPY, E.E., BAUDRIMONT, I. and BETBEDER, A.M. 1995. Prevention of nephrotoxicity of ochratoxin A, a food contaminant. Toxicol. Lett. 8283, 869877.
DE WILDT, R.M., MUNDY, C.R., GORICK, B.D. and TOMLINSON, I.M. 2000. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat. Biotechnol. 18, 989994. DELAUNAY-BERTONCINI, N., PICHON, V. and HENNION, M.C. 2003. Experimental comparison of three monoclonal antibodies for the class-selective immunoextraction of triazines. Correlation with molecular modeling and principal component analysis studies. J. Chromatogr. A 999, 315. DU, H., WU, M., YANG, W., YUAN, G., SUN, Y., LU, Y., ZHAO, S., DU, Q., WANG, J., YANG, S. ET AL. 2005. Development of miniaturized competitive immunoassays on a protein chip as a screening tool for drugs. Clin. Chem. 51, 368375. DUARTE, S.C., PENA, A. and LINO, C.M. 2010. A review on ochratoxin A occurrence and effects of processing of cereal and cereal derived food products. Food Microbiol. 27, 187198. DUFNER, P., JERMUTUS, L. and MINTER, R.R. 2006. Harnessing phage and ribosome display for antibody optimisation. Trends Biotechnol. 24, 523529.
414
X. WANG ET AL.
ERKEKOGLU, P., SABUNCUOGLU, S., AYDIN, S., SAHIN, G. and GIRAY, B. 2010. Determination of seasonal variations in serum ochratoxin A levels in healthy population living in some regions of Turkey by enzyme-linked immunosorbent assay. Toxicon 55, 507513. GELDERBLOM, W.C., ABEL, S., SMUTS, C.M., MARNEWICK, J., MARASAS, W.F., LEMMER, E.R. and RAMLJAK, D. 2001. Fumonisin-induced hepatocarcinogenesis: Mechanisms related to cancer initiation and promotion. Environ. Health Perspect. 109(Suppl. 2), 291300. GHALI, R., HMAISSIA-KHLIFA, K., GHORBEL, H., MAAROUFI, K. and HEDILI, A. 2009. HPLC determination of ochratoxin A in high consumption Tunisian foods. Food Control 20, 716720. HUST, M. and DUBEL, S. 2004. Mating antibody phage display with proteomics. Trends Biotechnol. 22, 814. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC) 1993. Ochratoxin A some naturally occurring substances: Food items and constituents, heterocyclic aromatic amines and mycotoxins. In Monographs on the Evaluation of Carcinogenic Risk to Humans, Vol. 56 (the Secretariat of the World Health Organization, ed.) pp. 489521, IARC Press, Lyon, France. INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC) 2002. Monographs on the Evaluation of Carcinogenic Risks of Chemicals to Human, Vol.82, Some Traditional Herbal Medicines, Some Mycotoxins, Naphtalene and Styrene, p. 301, IARC Press, Lyon, France. JOOSTEN, H.M., GOETZ, J., PITTET, A., SCHELLENBERG, M. and BUCHELI, P. 2001. Production of ochratoxin A by Aspergillus carbonarius on coffee cherries. Int. J. Food Microbiol. 65, 3944. LENSEN, J.F., WIJNHOVEN, T.J., KUIK, L.H., VERSTEEG, E.M., HAFMANS, T., ROPS, A.L., PAVAO, M.S., VAN DER VLAG, J., VAN DEN HEUVEL, L.P., BERDEN, J.H. ET AL. 2006. Selection and characterization of a unique phage display-derived antibody against dermatan sulfate. Matrix Biol. 25, 457461. LIU, Y.H., JIN, M.J., GUI, W.J., CHENG, J.L., GUO, Y.R. and ZHU, G.N. 2007. Hapten design and indirect competitive immunoassay for parathion determination: Correlation with molecular modeling and principal component analysis. Anal. Chim. Acta 591, 173182. LIU, B.H., TSAO, Z.J., WANG, J.J. and YU, F.Y. 2008. Development of a monoclonal antibody against ochratoxin A and its application in enzyme-linked immunosorbent assay and gold nanoparticle immunochromatographic strip. Anal. Chem. 80, 70297035. MACBEATH, G. and SCHREIBER, S.L. 2000. Printing proteins as microarrays for high-throughput function determination. Science 289, 17601763. MANTLE, P.G. 2000. Uptake of radiolabelled ochratoxin A from soil by coffee plants. Phytochemistry 53, 377378. MARASAS, W.F. 2001. Discovery and occurrence of the fumonisins: A historical perspective. Environ. Health Perspect. 109(Suppl. 2), 239243.
MEDINA, A., JIMENEZ, M., GIMENO-ADELANTADO, J.V., VALLE-ALGARRA, F.M. and MATEO, R. 2005. Determination of ochratoxin A in beer marketed in Spain by liquid chromatography with uorescence detection using lead hydroxyacetate as a clean-up agent. J. Chromatogr.A 1083, 713. MOTELIN, G.K., HASCHEK, W.M., NESS, D.K., HALL, W.F., HARLIN, K.S., SCHAEFFER, D.J. and BEASLEY, V.R. 1994. Temporal and dose-response features in swine fed corn screenings contaminated with fumonisin mycotoxins. Mycopathologia 126, 2740. PAEPENS, C., DE SAEGER, S., SIBANDA, L., BARNA-VETRO, I., LEGLISE, I., VAN HOVE, F. and VAN PETEGHEM, C. 2004. A ow-through enzyme immunoassay for the screening of fumonisins in maize. Anal. Chim. Acta 523, 229235. PAEPENS, C., DE SAEGER, S., VAN POUCKE, C., DUMOULIN, F., VAN CALENBERGH, S. and VAN PETEGHEM, C. 2005. Development of a liquid chromatography/tandem mass spectrometry method for the quantication of fumonisin B1, B2 and B3 in cornakes. Rapid Commun. Mass Spectrom. 19, 20212029. PFOHL-LESZKOWICZ, A., PETKOVA-BOCHAROVA, T., CHERNOZEMSKY, I.N. and CASTEGNARO, M. 2002. Balkan endemic nephropathy and associated urinary tract tumours: A review on aetiological causes and the potential role of mycotoxins. Food Addit. Contam. 19, 282302. PITT, J.I. 2000. Toxigenic fungi: Which are important? Med. Mycol. 38(Suppl. 1), 1722. RINGOT, D., CHANGO, A., SCHNEIDER, Y.J. and LARONDELLE, Y. 2006. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem. Biol. Interact. 159, 1846. ROTTINGHAUS, G.E., COATNEY, C.E. and MINOR, H.C. 1992. A rapid, sensitive thin layer chromatography procedure for the detection of fumonisin B1 and B2. J. Vet. Diagn. Invest. 4, 326329. SAGE, L., KRIVOBOK, S., DELBOS, E., SEIGLE-MURANDI, F. and CREPPY, E.E. 2002. Fungal ora and ochratoxin a production in grapes and musts from France. J. Agric. Food Chem. 50, 13061311. SANTOS, E.A. and VARGAS, E.A. 2002. Immunoafnity column clean-up and thin layer chromatography for determination of ochratoxin A in green coffee. Food Addit. Contam. 19, 447458. SIMARRO DOORTEN, A.Y., BULL, S., VAN DER DOELEN, M.A. and FINK-GREMMELS, J. 2004. Metabolism-mediated cytotoxicity of ochratoxin A. Toxicol. In Vitro 18, 271277. TOTHILL, I.E. 2001. Biosensors developments and potential applications in the agricultural diagnosis sector. Comput. Electron. Agric. 30, 205218. VISCONTI, A., PASCALE, M. and CENTONZE, G. 1999. Determination of ochratoxin A in wine by means of immunoafnity column clean-up and high-performance liquid chromatography. J. Chromatogr. A 864, 89101. WANG, S., QUAN, Y., LEE, N. and KENNEDY, I.R. 2006. Rapid determination of fumonisin B1 in food samples by enzyme-linked immunosorbent assay and colloidal gold immunoassay. J. Agric. Food Chem. 54, 24912495.
415
X. WANG ET AL.
WILSON, T.M., ROSS, P.F., OWENS, D.L., RICE, L.G., GREEN, S.A., JENKINS, S.J. and NELSON, H.A. 1992. Experimental reproduction of ELEM. A study to determine the minimum toxic dose in ponies. Mycopathologia 117, 115120. YOSHIZAWA, T., YAMASHITA, A. and LUO, Y. 1994. Fumonisin occurrence in corn from high- and low-risk areas for human esophageal cancer in China. Appl. Environ. Microbiol. 60, 16261629.
YU, F.Y. and CHU, F.S. 1999. Production and characterization of a monoclonal anti-anti-idiotype antibody against fumonisin B(1). J. Agric. Food Chem. 47, 48154820. ZHANG, Q., WANG, L., AHN, K.C., SUN, Q., HU, B., WANG, J. and LIU, F. 2007. Hapten heterology for a specic and sensitive indirect enzyme-linked immunosorbent assay for organophosphorus insecticide fenthion. Anal. Chim. Acta 596, 303311.
416